Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament

DSpace/Manakin Repository

Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament

Citable link to this page

. . . . . .

Title: Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament
Author: McPhie, David C.
Citation: Old Drugs, New Uses: Solving a Hatch-Waxman Patent Predicament (2003 Third Year Paper)
Full Text & Related Files:
Abstract: In early 2003, two panels of the Federal Circuit clashed in a pair of cases (Warner-Lambert v. Apotex and Allergan v. Alcon) dealing with the question of whether an action for inducement of infringement could be leveled against a generic drug manufacturer seeking FDA approval for an unpatented drug with both patented and unpatented uses. This paper takes up this debate, analyzing the interpretive puzzles presented in the application of the intricate Hatch-Waxman Act to this set of facts, arguing that the correct interpretation weaves elements from both panels’ approaches. It finishes with an alternative solution borrowed from a lesson in copyright.
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852107

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters